| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/26/2011 | US7932056 Crustaceans as production systems for therapeutic proteins |
| 04/26/2011 | US7932043 Use of monoclonal antibodies to distinguish protein conformational isoforms |
| 04/26/2011 | US7931903 Internalizing anti-CD74 antibodies and methods of use |
| 04/26/2011 | US7931901 T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof |
| 04/26/2011 | US7931900 Method for the treatment of multiple sclerosis by inhibiting IL-17 activity |
| 04/26/2011 | US7931898 Methods and compositions for inhibiting binding of IgE to a high affinity receptor |
| 04/26/2011 | US7931897 Therapeutic agent for hematopoietic tumors |
| 04/26/2011 | US7931895 Monoclonal antibodies with enhanced ADCC function |
| 04/26/2011 | CA2501984C Erythropoietin receptor binding antibodies |
| 04/26/2011 | CA2446112C A method for regulating immune function in primates using the foxp3 protein |
| 04/26/2011 | CA2420231C Antibodies to human il-1.beta. |
| 04/26/2011 | CA2416572C Bispecific antibody for target cell-specific stimulation of the apo-1 cell surface receptor |
| 04/26/2011 | CA2309602C Methods and compositions for enhancing immune response and for the production of in vitro mabs |
| 04/26/2011 | CA2298934C Vectors derived from antibodies for transferring substances into cells |
| 04/26/2011 | CA2215394C Il-17 receptor |
| 04/26/2011 | CA2201482C Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/21/2011 | WO2011047262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/21/2011 | WO2011047180A1 Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereof |
| 04/21/2011 | WO2011047083A1 Antibodies against epha10 |
| 04/21/2011 | WO2011046958A1 Use of il-17 receptor a antigen binding proteins |
| 04/21/2011 | WO2011046623A2 Hiv-1 antibodies |
| 04/21/2011 | WO2011046515A1 Antiproliferative agent |
| 04/21/2011 | WO2011046309A2 A diagnostic marker for hepatocellular carcinoma comprising anti-fasn autoantibodies and a diagnostic composition for hepatocellular carcinoma comprising antigens thereof |
| 04/21/2011 | WO2011046218A1 Hansenula polymorpha capable of producing antibody, process for production of antibody utilizing same, and antibody produced from same |
| 04/21/2011 | WO2011045945A1 ANTIBODY RECOGNIZING TURN STRUCTURE IN AMYLOID β |
| 04/21/2011 | WO2011045704A1 Cancer treatment |
| 04/21/2011 | WO2011045573A2 Staphylococcal antigens |
| 04/21/2011 | WO2011045352A2 Spleen tyrosine kinase and brain cancers |
| 04/21/2011 | WO2011045202A1 Selective antagonist or agonist of amhrii for modulating fertility |
| 04/21/2011 | WO2011045080A2 Monoclonal antibodies to progastrin and their uses |
| 04/21/2011 | WO2011026132A3 Methods and compositions for the inhibition of transplant rejection |
| 04/21/2011 | WO2011025964A3 Therapeutic dll4 binding proteins |
| 04/21/2011 | WO2011020529A8 Antibodies for the detection of integrin complexes in ffpe material |
| 04/21/2011 | WO2011015924A3 Vectors and compounds for expression of recombinant trastuzumab |
| 04/21/2011 | WO2011015918A3 Vectors and compounds for expression of recombinant cetuximab |
| 04/21/2011 | WO2011015916A3 Vectors and compounds for expression of recombinant infliximab |
| 04/21/2011 | WO2010142551A8 Amino acid sequences directed against receptors to cytokines belonging to the il-17 family |
| 04/21/2011 | WO2010141716A3 Methods and materials for diagnosing light chain amyloidosis |
| 04/21/2011 | WO2010138803A3 Herv-k antigens, antibodies, and methods |
| 04/21/2011 | WO2010138621A3 Diagnosing and treating iga nephropathy |
| 04/21/2011 | WO2010138184A3 Avian derived antibodies |
| 04/21/2011 | WO2010135717A3 Complement assays and uses thereof |
| 04/21/2011 | WO2010135585A3 Engineered type iv pilin of clostridium difficile |
| 04/21/2011 | WO2010132604A9 Neutralizing molecules to influenza viruses |
| 04/21/2011 | WO2010130832A3 Amino acid sequences directed against dickkopf-1 and polypeptides comprising the same for the treatment of diseases and disorders associated with bone loss and/or osteolytic lesions |
| 04/21/2011 | WO2010129270A3 Profiling fragments of elastic fibers and microfibrils as biomarkers for disease |
| 04/21/2011 | WO2010128265A3 Use of igg1 immunoglobulins and/or ligands of the cd32 receptor for treating inflammatory diseases and incidents via the mucosa |
| 04/21/2011 | WO2010094723A3 Improved anti-serum albumin binding variants |
| 04/21/2011 | WO2010040508A9 Bispecific anti-vegf/anti-ang-2 antibodies |
| 04/21/2011 | US20110093965 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 04/21/2011 | US20110093964 Uranium-chelating peptides and uses thereof |
| 04/21/2011 | US20110093962 Breast disease targets and uses thereof |
| 04/21/2011 | US20110093961 Mouse lambda light chain locus |
| 04/21/2011 | US20110092674 Non-Functional P2X7 Receptor |
| 04/21/2011 | US20110092388 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 04/21/2011 | US20110091992 CRYSTALS AND STRUCTURE OF HUMAN IgG Fc VARIANT |
| 04/21/2011 | US20110091968 Monoclonal antibody specific to both human interferon-alpha subtype alpha 8 and its mutant proteins |
| 04/21/2011 | US20110091960 Compositions and Methods for Detection of Antibody Binding to Cells |
| 04/21/2011 | US20110091920 METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX |
| 04/21/2011 | US20110091881 Mycobacterial genes down-regulated during latency |
| 04/21/2011 | US20110091876 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
| 04/21/2011 | US20110091529 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 04/21/2011 | US20110091528 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 04/21/2011 | US20110091526 Parasite Vaccine |
| 04/21/2011 | US20110091508 Oligofluorinated cross-linked polymers and uses thereof |
| 04/21/2011 | US20110091495 Hcv e2 construct compositions and methods |
| 04/21/2011 | US20110091491 Hiv-1 gp41 neutralization domain and use thereof |
| 04/21/2011 | US20110091483 Canine Anti-CD20 Antibodies |
| 04/21/2011 | US20110091480 Antigen-Binding Proteins Targeting S. Aureus Orf0657n |
| 04/21/2011 | US20110091479 Novel anti-igf-ir antibodies and uses thereof |
| 04/21/2011 | US20110091477 Modulators of hepatocyte growth factor activator |
| 04/21/2011 | US20110091476 Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway Inhibitors |
| 04/21/2011 | US20110091475 Anti-Human Interleukin-20 Antibodies |
| 04/21/2011 | US20110091472 Compositions for treating psoriasis |
| 04/21/2011 | US20110091470 Anti-flt3 antibodies |
| 04/21/2011 | US20110091469 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 04/21/2011 | US20110091468 Connective tissue growth factor antibodies |
| 04/21/2011 | US20110091466 IgE ANTIBODIES FOR THE TREATMENT OF CANCER |
| 04/21/2011 | US20110091465 Polypeptides |
| 04/21/2011 | US20110091464 Novel peptides and protein and uses thereof |
| 04/21/2011 | US20110091463 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | US20110091462 Novel antigen binding dimer-complexes, methods of making and uses thereof |
| 04/21/2011 | US20110091461 Binding domain-immunoglobulin fusion proteins |
| 04/21/2011 | US20110091460 Receptor-targeting reagents |
| 04/21/2011 | US20110091458 Anti-il 13 human antibodies |
| 04/21/2011 | US20110091454 Methods and systems for annotating biomolecular sequences |
| 04/21/2011 | US20110091453 Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory diseases |
| 04/21/2011 | US20110091449 Isolation of Anti-Desmoglein 1 Antibodies by Phage Display of Pemphigus Foliaceus Autoantibodies |
| 04/21/2011 | US20110091446 Single domain antibodies capable of modulating bace activity |
| 04/21/2011 | US20110091417 Interleukin-22 Polypeptides, Nucleic Acids Encoding The Same And Methods For The Treatment Of Pancreatic Disorders |
| 04/21/2011 | US20110091416 Immunoglobulin fusion proteins |
| 04/21/2011 | US20110091413 Therapeutic use of interleukin-2 mutants |
| 04/21/2011 | US20110091386 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
| 04/21/2011 | US20110091384 Biomarker for identification of melanoma tumor cells |
| 04/21/2011 | US20110091379 Method for treating tumors and their metastases |
| 04/21/2011 | US20110091372 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | US20110089037 Biological particles |
| 04/21/2011 | CA2777717A1 Chimeric fibroblast growth factors with altered receptor specificity |
| 04/21/2011 | CA2777699A1 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 04/21/2011 | CA2777242A1 Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereof |